... the best potential for quality vision with ACRYSO...ical aberration by addressing the effects of over-...without increasing edge thickness. Human corneal ...hat provides improved image quality.,MTF (mea...
...tations provide comprehensive neurological monitor...to accurately access your patients neurological st...e, and a long history of achievements, Axon System...roven record of accurate and reliable performance....
...is a cost-effective, office-based ultrasound syste...lity of our more expensive ProSound models in a co...small exam rooms., ,The SSD-3500 is also DICOM...stem (iDMS) enables easy storage and retrieval of ...
...currently developing additional assays for the blo...3.47 million to date in contract funding from the ...as been used to develop the Procleix WNV Assay. Th...centers under an Investigational New Drug Applicat...
Medicine Products:(Date:5/16/2008)... ,What this country needs is more unemployed pol... /PRNewswire-FirstCall/ -- Although nearly all,vot...portant issues" list,a looming federal budgetary ...d by any of the current presidential candidates is...S. Senate Majority Leader Bill Frist., Jousting w...
(Date:5/16/2008)... HARRISBURG, Pa., May 16 /PRNewswire-USNewswi...4, is an opportunity to highlight the dedication,o...re citizens to become,trained EMS volunteers, acco...son., This year,s theme, "EMS: Your Life is Our M...ncy is or when it occurs, EMS is there to provide,...
(Date:5/16/2008)... WASHINGTON, May 16 /PRNewswire-USNewswire/ -...ed area of the Irrawaddy delta, survivors of,Cyclo...ere problems. Many,survivors still need assistance... are creating an increasingly dire situation., "T... more help to,recover from this disaster and get b...
(Date:5/16/2008)... Appeals for Funds Focus on Millions of Chi...re/ -- The U.S. Fund for UNICEF and The,Advertisin...ute and promote,a series of national public servic...s, including Ben Stiller, Nicole Ritchie, Joel Mad... designed to help survivors of the,Myanmar cyclone...
Breaking Medicine News(10 mins):Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3...ansfusion Service (IBTS) has discarded the new mac...ted blood after having spent €14m on the filter// ...intenance of bloodstocks a difficult challenge alt... the number of donations. According to their annua...
...inister of Karnataka said that around 176 babies a... program on the occasion of World Population Day//...ealth and Family Welfare and Rashtriya Grameen Aro...crease in population, the problems faced by people...
...udy published in the June issue of The American Jo...y be able to improve their cognitive function// an...ges such as incorporating memory exercises, health... reduction into their daily lives. “We’ve known f...
...ity tonight appealed to citizens and citizens grou...taff to help treat those injured in this evening's...al hospitals including KEM, V N Desai and Bhaba, w...tients at the casualty and emergency wards, appeal...
Other Medicine News:Health News:Simple Lifestyle Changes May Improve Cognitive Function and Brain Efficiency 2(Date:5/15/2008)...ion Most Affected by Disease -, WAYNE, N.J. and E...-,Bayer HealthCare Pharmaceuticals, Inc. and Onyx ...nced that Nexavar(R) (sorafenib) tablets,significa...=0.68;,p-value=0.014) in patients in the Asia-Paci...(HCC), or primary liver cancer versus those,receiv...
(Date:5/15/2008)...afety profile of BSI-201 in subjec..., May 15 /- BiPar Sciences, Inc., a,p... novel cancer therapies,today announced that data...,be presented at the 2008 American Society of Clin...s will be presented from the first in human Phase ...
(Date:5/15/2008)...ects depth and breadth of, collaboration with inv... diverse forms of cancer ..., the leading IV, bisphosphonate, on relapse rate ...r oral sessions to feature RAD001, first oral once...rst results of RECORD-1 study in renal cell ...
(Date:5/15/2008)...eared device to identify the, lipid core (fatty) ...ith complications of coronary st... InfraReDx, Inc. today,announced that physicians a...essfully used its LipiScan(TM) Coronary Imaging Sy...tion. This is the first patient in the,world in wh...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 12334 1MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 12334 2MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 12334 3Neuralstem Inc Announces Strategic Investment by Korean CJ CheilJedang Corporation 3419 1Neuralstem Inc Announces Strategic Investment by Korean CJ CheilJedang Corporation 3419 2Neuralstem Inc Announces Strategic Investment by Korean CJ CheilJedang Corporation 3419 3Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 1Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 2Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 3Survey Shows Most Women Cant Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3416 4In Combination With FOLFOX4 the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon 12331 1In Combination With FOLFOX4 the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon 12331 2... COPENHAGEN, June 4, 2007-A new study published t...pinion showed that,Cipralex® (escitalopram) wa...ute treatment of patients with major,depressive di...ng-term treatment. The study directly compared Cip...itor - ASRI) to duloxetine (a,serotonin and noradr...
... CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Introgen ...s clinical collaborators today,reported updated Ph... between abnormal p53, tumor responses and increas...ts with recurrent,squamous cell carcinoma of the h...nted today at the annual meeting of the American,S...
Other Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4